top of page

​

Recombinant Human KRAS4B (N-6His)
Recombinant Human GTPase Kras4B is produced by our E.coli expression system and the target gene encoding Met1-Lys169 is expressed with a 6His tag at the N-terminus.

Recombinant Human KRAS4B (N-6His)

SKU: CR69-10ug
$47.00Price
Quantity
[{"key":"CR69-10ug","value":"Backorder"},{"key":"CR69-500ug","value":"Backorder"},{"key":"CR69-50ug","value":"Backorder"},{"key":"CR69-1mg","value":"Backorder"}]

Contact Us

Phone: 800-943-6396 ext#1

Email: orders@bonopusbio.com

Distributors

Shipping Information

$48 Standard Overnight flat rate for products shipped in room temperature within the United States.

 

Additional $27 Ice Packs shipment fee is required for liquid proteins.

 

Please contact us to order for  international shipments.

Endotoxin
Less than 0.1 ng/ug (1 EU/ug) as determined by LAL test.
Accession Number
P01116-2
Species
Human
Expression System
E.coli
Target Sequence
Met1-Lys169
Tag
N-6His
Formulation
Lyophilized from a 0.2 um filtered solution of PBS, pH7.4.
Packaging
Ambient
Background
K-Ras belongs to the small GTPase superfamily, Ras family. As other members of the Ras family, K-Ras is a GTPase and is an early player in many signal transduction pathways. It is usually tethered to cell membranes because of the presence of an isoprenyl group on its C-terminus. K-Ras functions as a molecular on/off switch. Ras proteins bind GDP/GTP and possess intrinsic GTPase activity. Plays an important role in the regulation of cell proliferation. Plays a role in promoting oncogenic events by inducing transcriptional silencing of tumor suppressor genes (TSGs) in colorectal cancer (CRC) cells in a ZNF304-dependent manner. Besides essential function in normal tissue signaling, the mutation of a K-Ras gene is an essential step in the development of many cancers. Several germline K-Ras mutations have been found to be associated with Noonan syndrome[4] and cardio-facio-cutaneous syndrome. Somatic K-Ras mutations are found at high rates in Leukemias, colon cancer, pancreatic cancer and lung cancer.
Purity
Greater than 95% as determined by reducing SDS-PAGE.
Ki-Ras; c-K-ras; KRAS2; RASK2; CFC2
Alternative Names
Be the first to submit a citation to get publication rewards
Citation
NA
Activity
bottom of page